Drug Profile
CS 92
Alternative Names: AzddMeC; AzidodideoxymethylcytidineLatest Information Update: 12 Apr 2007
Price :
$50
*
At a glance
- Originator Emory University; University of Georgia
- Developer Triangle Pharmaceuticals
- Class Antiretrovirals; Nucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 27 Apr 1998 Suspended-II for HIV infections treatment in USA (Unknown route)
- 12 Dec 1997 Phase-II clinical trials for HIV infections treatment in USA (Unknown route)